PF-06260414

PF-06260414

PF-06260414Musculoskeletal diseases
CAS: 1612755-71-1
MF: C14H14N4O2S
MW: 302.35
适应症
pain disorder
作用靶点
Opioid receptors
用途

An experimental SARM for muscle failure research has entered Phase I clinical trials.

规格标准
>99%
描述

概况

PF-06260414 is an oral nonsteroidal SARM with potent anabolic effects in muscle, targeting sarcopenia and muscle decline in early clinical trials. It enhances muscle mass, strength, and bone health with tissue-specific benefits and fewer side effects than steroids. Used in sports nutrition research and age-related muscle wasting studies.

Synonyms: PF6260414; PF-6260414; 1-Isoquinolinecarbonitrile,6-[(4R)-tetrahydro-4-methyl-1,1-dioxido-2H-1,2,6-thiadiazin-2-yl]-; PF-06260414>=98%(HPLC); 6-((4R)-4-Methyl-1,1-dioxo-1,2,6-thiadiazinan-2-yl)isoquinoline-1-carbonitrile

Product Categories: SARM series

Mol File: 1612755-71-1.mol

物化性质

Boiling point: 539.7±53.0°C(Predicted)

Density: 1.45±0.1g/cm3(Predicted)

Storage temp.: room temp

Solubility: DMSO: 5mg/mL, clear (warmed)

Form: powder

Color: light orange to dark orange

MSDS信息

实验数据

Pharmacodynamics

Mechanism Of Action